A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
Clinical trial NCT02724085 · COMPLETED
Trial details
- NCT number
- NCT02724085
- Sponsor
- Tetraphase Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2016-09-28
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.